Lexeo Therapeutics (LXEO) Other Gross PP&E Adjustments (2022 - 2026)

Lexeo Therapeutics has disclosed Other Gross PP&E Adjustments across 5 years of filings, most recently posting -$4.3 million for Q1 2026.

• Other Gross PP&E Adjustments for Q1 2026 came in at -$4.3 million, down 2245.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.3 million (down 2245.73% YoY), and the FY2025 annual result was -$4.7 million, up 28.46% from the prior year.
• Other Gross PP&E Adjustments came in at -$4.3 million for Q1 2026 at Lexeo Therapeutics, up from -$4.7 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $678000.0 in Q3 2025 to a low of -$10.2 million in Q4 2022.
• The 5-year median for Other Gross PP&E Adjustments is -$3.1 million (2023), against an average of -$3.5 million.
• Across the five-year window, Other Gross PP&E Adjustments surged 266.96% in 2025 and plunged 2245.73% in 2026, its largest moves.
• Lexeo Therapeutics' Other Gross PP&E Adjustments stood at -$10.2 million in 2022, then jumped by 86.24% to -$1.4 million in 2023, then slumped by 367.74% to -$6.6 million in 2024, then increased by 28.46% to -$4.7 million in 2025, then advanced by 9.11% to -$4.3 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$4.3 million (Q1 2026), -$4.7 million (Q4 2025), and $678000.0 (Q3 2025), per Business Quant data.